Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
VA launches trial of GLP-1 drugs to treat alcohol use disorder in veterans The Department of Veterans Affairs is launching a new clinical trial to test whether GLP-1 drugs used for weight loss and type 2 diabetes can treat alcohol use disorder in veterans
It attempts to address the knowledge gaps and give a comprehensive understanding of the treatments long-term effects, resulting in better clinical decisions and patient outcomes
We design targeted treatment programs built to get real, lasting resultsespecial
Schisandrin B reverses doxorubicin resistance through inhibiting p-glycoprotein and promoting proteasome-mediated degradation of survivin
J Clin Endocrinol Metab 86 (8): 3853-60
US$ 21.89
US$ 27.49
US$ 22.26
US$ 26.55
